HIV studies: progress in microbicides, dead end for an immune-boosting strategy.
Joan
J
Stephenson
D017088:AIDS-Related Opportunistic Infections / Q000517:prevention & control*; D000818:Animals; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D005260:Female; D015658:HIV Infections / Q000517:prevention & control*; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D007376:Interleukin-2 / Q000627:therapeutic use*; D008251:Macaca; D009282:Naphthalenesulfonates / Q000627:therapeutic use; D011108:Polymers / Q000627:therapeutic use; D014622:Vaginal Creams, Foams, and Jellies
D019380:Anti-HIV Agents; D007155:Immunologic Factors; D007376:Interleukin-2; D009282:Naphthalenesulfonates; C120231:PRO 2000; D011108:Polymers; D014622:Vaginal Creams, Foams, and Jellies